Opal Wealth Advisors, LLC

Position in AMGN — Amgen Inc

CIK 1844201 JERICHO, NY

Position in AMGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$504,795

+$13,261 QoQ

Shares Held

1,394

-0.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.44%

of 13F equity value

Holder Rank

#2,174

of 3,140 holders

Holding Since

Dec 2020

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Opal Wealth Advisors, LLC holds $5,257,340 across 8 Drug Manufacturers - General names. AMGN ranks #5 (9.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	6,171	$1,552,870
2	LLY	ELI LILLY & Co	786	$942,752
3	NVS	Novartis AG	4,383	$686,903
4	JNJ	Johnson & Johnson	2,037	$517,336
5	AMGN	Amgen Inc This page	1,394	$504,795
6	AZN	Astrazeneca PLC	2,227	$422,283
7	MRK	Merck & Co., Inc.	2,998	$385,243
8	PFE	Pfizer Inc	10,181	$245,158

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$504,795	1,394	-0.2%	Shares	Sole	2026-07-20
2026-03-31	$491,534	1,397	+0.2%	Shares	Sole	2026-04-14
2025-12-31	$456,270	1,394	-0.4%	Shares	Sole	2026-01-26
2025-09-30	$395,080	1,400	+1.2%	Shares	Sole	2025-10-24
2025-06-30	$386,147	1,383	-1.5%	Shares	Sole	2025-07-14
2025-03-31	$437,416	1,404	+1.5%	Shares	Sole	2025-04-16
2024-12-31	$360,465	1,383	-1.1%	Shares	Sole	2025-01-29
2024-09-30	$450,771	1,399	-1.5%	Shares	Sole	2024-10-15
2024-06-30	$443,991	1,421	-0.8%	Shares	Sole	2024-07-12
2024-03-31	$407,146	1,432	-23.3%	Shares	Sole	2024-04-11
2023-12-31	$538,021	1,868	+1.9%	Shares	Sole	2024-01-22
2023-09-30	$492,905	1,834	+8.3%	Shares	Sole	2023-10-18
2023-06-30	$375,879	1,693	+95.9%	Shares	Sole	2023-07-27
2021-06-30	$210,600	864	-20.1%	Shares	Sole	2021-08-02
2020-12-31	$248,543	1,081	—	Shares	Sole	2021-02-11
No filing history on record for this holder in this stock.